Manage Your Liver
Q:

What can be done to protect your liver if you cannot afford costly antiviral Hepatitis C treatment?

What can be done to protect your liver if you cannot afford costly antiviral Hepatitis C treatment?
A:

Eliminating the virus in patients’ body has been deemed as the only approach to treat hepatitis C. Direct-acting antiviral drugs (DDAs) launched in recent years are proved to be more effective than interferon, but they are very expensive, thus arousing great debate in the society. Take the latest DAA as example, the cost of a twelve-week treatment is $94,500, that means a single pill costs $1125. Patients with cirrhosis who have failed prior treatment require 24 weeks of DAA treatment [1], this amount is unaffordable to the majority of the public. With other obstacles such as side effects and low effectiveness, are there other options for hepatitis C patients?

 

Although liver damage in Hepatitis C patients is caused by the hepatitis virus, Dr. Howard Monsour, M.D. suggested that “it is more important 'how' your body responds to the presence of the hepatitis C virus in your liver than 'how much' virus is in your liver that counts." [2] The amount of virus in the body actually does not directly relate to the extent of liver damage. Therefore, patients should focus primarily on the health of liver cells (which can be reflected by the ALT level).

 

To the liver, the biggest threat is not the virus, but the chronic inflammation caused by attacks on the liver cells. In fact, some patients’ have normal liver function and health despite a high viral count [3]. This proves that presence of virus in the body does not necessarily bring inflammation. Therefore, antiviral treatment is not the only treatment option for hepatitis C. Patients who are not able to receive treatment should understand that it is possible to live with the virus; the key is to enhance protection of the liver and stop inflammation.

 

In view of this, patients’ top priority should be to stop inflammation and antiviral treatment is not the only approach. A large number of scientific studies and clinical reports have proven that there are treatment options other than DAAs that can reduce liver inflammation, repair liver cells and normalize ALT level which are also highly effective and gentler on the body. [4][5]


Undoubtedly, successful eradication of the virus is the most ideal to patients; however the sacrifices and risks are not affordable to everyone. Patients must understand that the main objective of treatment is to regain liver health and this can only be achieved when inflammation is stopped.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us